90217689 - AXIAL THERAPEUTICS

Information

• Trademark
• 90217689

• Source

• Serial Number

  90217689

• Registration Number

  7355827

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  September 28, 2020
  3 years ago

• Registration Date

  April 09, 2024
  4 months ago

• Transaction Date

  April 26, 2024
  3 months ago

• Status Date

  April 09, 2024
  4 months ago

• Published for Opposition Date

  November 23, 2021
  2 years ago

• Location Date

  March 06, 2024
  5 months ago

• First Use Anywhere Date

  October 01, 2022
  a year ago

• First Use In Commerce Date

  October 01, 2022
  a year ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MASON, JARED MICHAEL

• Attorney Name

  Ian W. Gillies

  Law Office Assigned Location Code

  N10

• Owners

  • AXIAL THERAPEUTICS, INC

Case File Statements

• DM0000: The mark consists of eight circles, each connected to a central donut circle by two horizontal lines at the left and right, one shorter vertical line at the top, one longer vertical line at the bottom, one short diagonal line at the lower-left, one longer diagonal line at the upper-left, one slightly longer diagonal line at the upper-right, and one longer diagonal line at the lower right. To the right of this is the stacked stylized wording "AXIAL THERAPEUTICS" where "AXIAL" is in larger-sized font and "THERAPEUTICS" is in smaller-sized font.
• GS0051: Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
• GS0011: Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic or microbe-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic or microbe-targeted pharmaceutical preparations for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
• GS0441: Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic or microbe-targeted pharmaceuticals
• DS0000: "THERAPEUTICS"
• GS0421: Providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic or microbe-targeted phamaceutical products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others

Case File Event Statements

• 10/1/2020 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 11/10/2020 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/11/2020 - 3 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 2/19/2021 - 3 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 2/25/2021 - 3 years ago

  5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 2/25/2021 - 3 years ago

  6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 2/25/2021 - 3 years ago

  7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 2/25/2021 - 3 years ago

  8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/22/2021 - 3 years ago

  9 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/22/2021 - 3 years ago

  10 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/22/2021 - 3 years ago

  11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/24/2021 - 3 years ago

  12 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 9/17/2021 - 2 years ago

  13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/17/2021 - 2 years ago

  14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/18/2021 - 2 years ago

  15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/15/2021 - 2 years ago

  16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/3/2021 - 2 years ago

  17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/23/2021 - 2 years ago

  18 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/23/2021 - 2 years ago

  19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/18/2022 - 2 years ago

  20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 6/17/2022 - 2 years ago

  21 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/17/2022 - 2 years ago

  22 - SOU EXTENSION 1 FILED Type: EXT1

• 6/17/2022 - 2 years ago

  23 - SOU EXTENSION 1 GRANTED Type: EX1G

• 6/21/2022 - 2 years ago

  24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/11/2023 - a year ago

  25 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/11/2023 - a year ago

  26 - SOU EXTENSION 2 FILED Type: EXT2

• 1/11/2023 - a year ago

  27 - SOU EXTENSION 2 GRANTED Type: EX2G

• 1/13/2023 - a year ago

  28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 2/17/2023 - a year ago

  29 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 2/17/2023 - a year ago

  31 - USE AMENDMENT FILED Type: IUAF

• 3/6/2023 - a year ago

  30 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 3/6/2023 - a year ago

  32 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 6/21/2023 - a year ago

  36 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 4/4/2023 - a year ago

  33 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT

• 4/4/2023 - a year ago

  34 - NON-FINAL ACTION E-MAILED Type: GNRT

• 4/4/2023 - a year ago

  35 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/21/2023 - a year ago

  37 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 7/18/2023 - a year ago

  38 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 10/4/2023 - 10 months ago

  39 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/26/2024 - 5 months ago

  40 - ASSIGNED TO LIE Type: ALIE

• 2/26/2024 - 5 months ago

  41 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/26/2024 - 5 months ago

  42 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/6/2024 - 5 months ago

  43 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 3/7/2024 - 5 months ago

  44 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 4/9/2024 - 4 months ago

  45 - REGISTERED-PRINCIPAL REGISTER Type: R.PR